Zhejiang Xinguang Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Zhejiang Xinguang Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Zhejiang Xinguang Pharmaceutical Co Ltd (300519) has a cash flow conversion efficiency ratio of -0.006x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-5.00 Million ≈ $-731.38K USD) by net assets (CN¥814.66 Million ≈ $119.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Zhejiang Xinguang Pharmaceutical Co Ltd (2011–2024)
Cash flow conversion efficiency of Zhejiang Xinguang Pharmaceutical Co Ltd from 2011 to 2024. This chart illustrates how Zhejiang Xinguang Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Zhejiang Xinguang Pharmaceutical Co Ltd stock quote for real-time trading data and today's change.
Zhejiang Xinguang Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Zhejiang Xinguang Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Zhejiang Xinguang Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Xinguang Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see market value of Zhejiang Xinguang Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Esso (Thailand) Public Company Limited
BK:BSRC
|
0.222x |
|
EVN Finance JSC
VN:EVF
|
-0.148x |
|
Firma Oponiarska DĘBICA SA
WAR:DBC
|
0.069x |
|
Hunan Creator Information Technologies Co Ltd Class A
SHE:300730
|
-0.007x |
|
Zhejiang Ming Jewelry Co Ltd
SHE:002574
|
-0.107x |
|
Hemisphere Properties India Limited
NSE:HEMIPROP
|
0.000x |
|
Lowland Investment Co
LSE:LWI
|
0.011x |
|
J.Kumar Infraprojects Limited
NSE:JKIL
|
0.122x |
Annual Cash Flow Conversion Efficiency for Zhejiang Xinguang Pharmaceutical Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Xinguang Pharmaceutical Co Ltd from 2011 to 2024. Review Zhejiang Xinguang Pharmaceutical Co Ltd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥830.53 Million ≈ $121.53 Million |
CN¥53.43 Million ≈ $7.82 Million |
0.064x | +1.91% |
| 2023-12-31 | CN¥844.12 Million ≈ $123.52 Million |
CN¥53.29 Million ≈ $7.80 Million |
0.063x | -57.11% |
| 2022-12-31 | CN¥858.89 Million ≈ $125.68 Million |
CN¥126.43 Million ≈ $18.50 Million |
0.147x | -12.50% |
| 2021-12-31 | CN¥846.22 Million ≈ $123.83 Million |
CN¥142.36 Million ≈ $20.83 Million |
0.168x | +23.53% |
| 2020-12-31 | CN¥826.94 Million ≈ $121.01 Million |
CN¥112.61 Million ≈ $16.48 Million |
0.136x | +10.82% |
| 2019-12-31 | CN¥799.71 Million ≈ $117.02 Million |
CN¥98.27 Million ≈ $14.38 Million |
0.123x | -0.23% |
| 2018-12-31 | CN¥753.26 Million ≈ $110.23 Million |
CN¥92.77 Million ≈ $13.58 Million |
0.123x | -30.03% |
| 2017-12-31 | CN¥705.81 Million ≈ $103.28 Million |
CN¥124.23 Million ≈ $18.18 Million |
0.176x | -6.98% |
| 2016-12-31 | CN¥640.46 Million ≈ $93.72 Million |
CN¥121.18 Million ≈ $17.73 Million |
0.189x | -53.11% |
| 2015-12-31 | CN¥309.35 Million ≈ $45.27 Million |
CN¥124.84 Million ≈ $18.27 Million |
0.404x | +0.67% |
| 2014-12-31 | CN¥249.00 Million ≈ $36.44 Million |
CN¥99.82 Million ≈ $14.61 Million |
0.401x | +40.78% |
| 2013-12-31 | CN¥201.97 Million ≈ $29.55 Million |
CN¥57.51 Million ≈ $8.42 Million |
0.285x | -25.23% |
| 2012-12-31 | CN¥141.62 Million ≈ $20.72 Million |
CN¥53.93 Million ≈ $7.89 Million |
0.381x | +15.50% |
| 2011-12-31 | CN¥104.32 Million ≈ $15.27 Million |
CN¥34.40 Million ≈ $5.03 Million |
0.330x | -- |
About Zhejiang Xinguang Pharmaceutical Co Ltd
Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food in China. It offers pharmaceutical products that cover respiratory, digestive, and urinary systems, as well as cardiovascular, cerebrovascular, trauma, and pediatric diseases. The company was incorporated in 1998 and is headquar… Read more